Evaluation of the Digestive and Metabolic Utilisation of Dietary Protein in Patients With Chronic Pancreatitis
NCT ID: NCT00957151
Last Updated: 2009-08-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
12 participants
INTERVENTIONAL
2004-04-30
2005-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Enzyme Therapy on Protein Metabolism in Chronic Pancreatitis
NCT01154608
Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency
NCT01427725
Creon After Pancreatic Surgery
NCT00535756
Efficacy of Pancrelipase on Postprandial Belching and Bloating.
NCT00266721
A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy
NCT00414908
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Creon
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* patients allergic to dairy proteins
* urinary incontinence affecting the measurement of nitrogen metabolism
* digestive disorder affecting the absorption of nutrients
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Solvay Pharmaceuticals
INDUSTRY
Hospital Avicenne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AP-HP
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Benamouzig, Pr
Role: PRINCIPAL_INVESTIGATOR
Department of Gastroenterology
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
04007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.